We work with a number of academic labs to develop novel techniques and foundational technologies to improve the Synthetic Biology toolbox. For instance, we work on HT strain engineering projects and novel cell-free technology.
We have the experience and track record to work with companies ranging in size from early stage start-ups to large corporations. We build novel workflows with young companies to support the proof of concept stage and also work with SMEs and large companies and manufacturers to deliver on specific R&D projects.
The SARS-CoV-2 pandemic has shown how the rapid rise in demand for patient and community sample testing, required for tracing and containing a highly infectious disease, has quickly overwhelmed testing capability globally.